Savara Inc (SVRA)
3.36
+0.12
(+3.70%)
USD |
NASDAQ |
Nov 22, 16:00
3.36
0.00 (0.00%)
After-Hours: 20:00
Savara Enterprise Value: 383.75M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 383.75M |
| November 21, 2024 | 363.16M |
| November 20, 2024 | 344.28M |
| November 19, 2024 | 311.67M |
| November 18, 2024 | 315.10M |
| November 15, 2024 | 318.54M |
| November 14, 2024 | 354.58M |
| November 13, 2024 | 364.87M |
| November 12, 2024 | 464.41M |
| November 11, 2024 | 505.60M |
| November 08, 2024 | 488.44M |
| November 07, 2024 | 493.90M |
| November 06, 2024 | 459.73M |
| November 05, 2024 | 425.56M |
| November 04, 2024 | 439.23M |
| November 01, 2024 | 422.15M |
| October 31, 2024 | 428.13M |
| October 30, 2024 | 428.98M |
| October 29, 2024 | 435.81M |
| October 28, 2024 | 408.48M |
| October 25, 2024 | 401.64M |
| October 24, 2024 | 377.73M |
| October 23, 2024 | 389.69M |
| October 22, 2024 | 398.23M |
| October 21, 2024 | 417.02M |
| Date | Value |
|---|---|
| October 18, 2024 | 449.48M |
| October 17, 2024 | 430.69M |
| October 16, 2024 | 446.06M |
| October 15, 2024 | 430.69M |
| October 14, 2024 | 432.40M |
| October 11, 2024 | 451.19M |
| October 10, 2024 | 422.15M |
| October 09, 2024 | 430.69M |
| October 08, 2024 | 452.90M |
| October 07, 2024 | 446.06M |
| October 04, 2024 | 459.73M |
| October 03, 2024 | 458.02M |
| October 02, 2024 | 473.40M |
| October 01, 2024 | 488.77M |
| September 30, 2024 | 531.49M |
| September 27, 2024 | 602.87M |
| September 26, 2024 | 602.87M |
| September 25, 2024 | 588.06M |
| September 24, 2024 | 632.50M |
| September 23, 2024 | 663.78M |
| September 20, 2024 | 644.02M |
| September 19, 2024 | 668.71M |
| September 18, 2024 | 635.79M |
| September 17, 2024 | 634.15M |
| September 16, 2024 | 616.04M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-39.70M
Minimum
Nov 26 2019
738.66M
Maximum
Jul 11 2024
167.12M
Average
50.41M
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 389.04B |
| Pulmatrix Inc | 11.57M |
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.25M |
| Total Expenses (Quarterly) | 26.36M |
| EPS Diluted (Quarterly) | -0.11 |
| Earnings Yield | -12.50% |
| Normalized Earnings Yield | -25.14 |